SERIES 3 | EPISODE 1: Examining the Controversy Around Patent Ductus Arteriosus (PDA) in Preterm Infants

GUEST: Souvik Mitra, MD,  MSc
Assistant Professor & Neonatologist
Department of Pediatrics, Dalhousie University & IWK Health Centre, Halifax
Social Media Editor, International Society of Evidence Based Neonatology

The treatment of patent ductus arteriosus (PDA) in preterm infants is the focus of much debate and controversy. Dr. Souvik Mitra offers insight for patient’s families and caregivers as to how recent research has impacted our understanding of PDAs and what the future might hold for treatment options.

Dr Souvik Mitra is a neonatologist and researcher based in Halifax, Nova Scotia. His primary research interest is improving outcomes of preterm babies with a patent ductus arteriosus (PDA), both through systemic review of current evidence and generation of new evidence through clinical research. He is the Principal Investigator of an ongoing CIHR-funded pan-Canadian study comparing the different medications used for treating a PDA, as well as the lead on several Cochrane Neonate systematic reviews on this topic. Dr. Mitra is also the social media editor for the International Society for Evidence-Based Neonatology. 

You can follow the society on Twitter at @EBNEO and Dr. Mitra himself at @souvik_neo.